ViCentra Expands Leadership Team
ViCentra announced the appointment of former Dexcom and Medtronic Diabetes leaders to new executive roles.
The company appointed Karen Baxter, former VP and GM at Dexcom, as SVP of sales for Europe, and Jay Little, a longtime commercialization and market access executive at Medtronic Diabetes, as VP of strategy and business development.
Baxter and Little bring nearly 40 years of combined experience in commercializing diabetes-related medical devices.
The appointments follow the company's $85 million funding round announced last month, as ViCentra continues to advance its Kaleido patch pump system.
No direct quotes available in the text.
Author's summary: ViCentra appoints new leaders from Dexcom and Medtronic Diabetes.
More News
- Kelly Vedovelli révèle sa vie amoureuse
- Game Preview: Islanders vs Lightning
- Hamilton urges Ferrari to make 'personnel changes' ahead of F1 2026
- How former Gonzaga stars perform in NBA
- NBA: Spurs at Timberwolves
- Islanders vs. Lightning (Dec 6, 2025) Pregame
- Guadeloupean artist Kelly Sinnapah Mary wins French art prize at Art Basel Miami Beach
- Kelly Massol : « J’ai réalisé 40% de mon ambition »
- Spurs' Kelly Olynyk: Ongoing Decline in Playing Time and Role
- Pelicans' Questionable Offseason Trade Looks Better After Saddiq Bey's Rise